MERTK and cardiovascular disorder: ADAM17 (a disintegrin and metalloprotease 17) is responsible for cleavage of MerTK, resulting in defective efferocytosis that contributes to accumulation of apoptotic cells and tissue injury in cardiovascular diseases including atherosclerosis [3].